Zura Bio (ZURA)Montanova Capital, LLC added to its stake +612K shares

5.47M

Shares reported · +612K vs prior quarter

0.61%

Disclosed portfolio weight

$23.7M

Reported value

Holdings as of

Sep 30, 2025

Filed

Nov 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 24, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 24, 2025, the Board of Directors of (the “Board”) of Zura Bio Limited (the “Company”) adopted an Executive Severance Benefit Plan (the “Severance Plan”) pursuant to which certain employees, including the Company’s current named executive officers, are eligible to participate.”
2. Oct 8, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 8, 2025, Robert Lisicki, Chief Executive Officer (principal executive officer) and member of the Board of Directors of Zura Bio Limited (the “Company”) informed the Company that he is taking a medical leave of absence, effective October 10, 2025.”
3. Nov 13, 2025Company filing · Form 8-K · ResultsReported its results

What came next

1. Dec 11, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 11, 2025, Arnout Ploos van Amstel notified Zura Bio Limited (the “Company”) of his decision to resign from the Board of Directors of the Company (the “Board”) and as a member of the Nominating and Governance Committee of the Board effective immediately.”
2. Dec 29, 2025Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 2 more items)
3. Jan 20, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On January 20, 2026, Robert Lisicki notified the Board of Directors (the “Board”) of Zura Bio Limited (the “Company”) that he was resigning as the Company’s Chief Executive Officer, principal executive officer and member of the Board, effective as of January 21, 2026 (the “Effective Date”).”
4. Feb 21, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On February 21, 2026, Neil Graham notified Zura Bio Limited (the “Company”) of his decision to resign from the Company’s board of directors (the “Board”), effective February 21, 2026.”
5. Feb 24, 2026Company filing · Form 8-K · Material agreement, ResultsSigned an important agreement, and reported its results (and 1 more item)

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Zura Bio

For Zura Bio, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ZURA page.

How this filing works

• SEC Form 13F

Other disclosures at Zura Bio

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRMay 14, 2026
• SEC Form 13F-HRFeb 17, 2026
• SEC Form 4Nov 27, 2024

Everything OQRO holds on this company is on its ZURA page.